Clarus Lifesciences III, L.P. is a venture capital fund based in Cambridge, Massachusetts. According to its most recent Form D, filed Jun 19, 2014, it has sold $234,160,000 of interests to 16 investors since its first sale in Feb 2014. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Clarus Ventures III, LLC; Nicholas Galakatos; Clarus Ventures III GP, L.P.
- Total raised
- $234,160,000Cumulative sales reported on Form D
- Investors
- 16
- First sale
- Feb 7, 2014
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Clarus Ventures III, LLC; Nicholas Galakatos; Clarus Ventures III GP, L.P
- Latest Form D
- Jun 19, 2014
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Raise history
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| Jun 19, 2014 | Form D/A (amendment) | $234,160,000 | 16 | SEC.gov ↗ |
| Feb 6, 2014 | Form D | $0 | 0 | SEC.gov ↗ |
2 Form D filings in the SEC's electronic records (2008 onward), the earliest on Feb 6, 2014. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Foundations that report holding this fund
| Foundation | State | Value reported | Basis | Tax year ended |
|---|---|---|---|---|
| Richard King Mellon Foundation | PA | $97,483 | fair market value | Dec 31, 2024 |
1 private foundation listed this fund by name among the investments on its IRS Form 990-PF. The value is the year-end figure the foundation reported, exactly as filed (fair market value where given, otherwise book value); holdings may have changed since, and other investors in the fund are not listed. Matched by the fund's full name; not verified by AltMountain or by the fund. Source: Internal Revenue Service, Form 990 series e-file data.
Questions about Clarus Lifesciences III, L.P.
What is the minimum investment for Clarus Lifesciences III, L.P.?
Clarus Lifesciences III, L.P.'s latest Form D, filed Jun 19, 2014, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Clarus Lifesciences III, L.P.?
Clarus Lifesciences III, L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Clarus Lifesciences III, L.P. raised?
Clarus Lifesciences III, L.P. reports $234,160,000 sold from 16 investors on its Form D filed Jun 19, 2014. This is cumulative sales since the offering began, not current assets or performance.
Where is Clarus Lifesciences III, L.P. based?
Clarus Lifesciences III, L.P. is based in Cambridge, Massachusetts.
When did Clarus Lifesciences III, L.P. launch?
Clarus Lifesciences III, L.P. reports its first sale in Feb 2014.
Size compared with every venture capital fund
Raised more than 97% of the 535 venture capital funds based in Massachusetts, and more than 99% of all 14,864 that report sales.